The Gross Margin of Samsung Biologics Co Ltd (207940.KS) is 50.38%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 50.38% |
| 2023-12-31 | 48.79% |
| 2022-12-31 | 48.93% |
| 2021-12-31 | 46.33% |
| 2020-12-31 | 35.72% |
| 2019-12-31 | 27.37% |
| 2018-12-31 | 27.09% |
| 2017-12-31 | 28.37% |
| 2016-12-31 | 9.01% |
| 2015-12-31 | -25.75% |